Maternus-Kliniken AG

MAK

Equity

ISIN DE0006044001 / Valor 335800

Xetra (2024-09-18)

EUR 1.74+2.35%

Maternus-Kliniken AG
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Maternus-Kliniken AG is a German healthcare company that operates rehabilitation clinics, nursing homes, and senior residences.

Summarized from source with an LLMView SourceSector: Healthcare

Revenue Decline

In the second quarter of 2023, Maternus-Kliniken AG reported a revenue of €50.7 million, which represents a 7.7% decrease compared to the €55.0 million recorded in the same period of the previous year.

Segment Performance

The revenue from the care segment for Maternus-Kliniken AG in Q2 2023 was €40.0 million, down by 4.3% from €41.8 million in Q2 2022. The rehabilitation segment saw a more significant decline of 18.5%, with revenues dropping from €12.4 million to €10.1 million.

EBITDA and Profitability

Maternus-Kliniken AG's EBITDA for the second quarter of 2023 was negative at -€1.0 million, a substantial drop from the positive €3.5 million reported in the same quarter of the previous year. Consequently, the EBITDA margin also fell from 6.5% to -2.0%.

Net Loss

The company reported a net loss of €9.2 million for Q2 2023, which is more than double the net loss of €4.5 million recorded in Q2 2022. This resulted in an earnings per share (EPS) of -€0.44, compared to -€0.22 in the previous year.

Equity and Balance Sheet

As of June 30, 2023, Maternus-Kliniken AG's equity was negative at -€48.5 million, a further decline from -€39.3 million as of June 30, 2022. The total balance sheet value increased slightly by 1.5% to €155.8 million from €153.4 million in the previous year.

Summarized from source with an LLMView Source

Key figures

-44.9%1Y

-67.8%3Y

-6.95%5Y

Performance

77.2%1Y

62.0%3Y

64.8%5Y

Volatility